Nabriva Therapeutics PLC (NASDAQ:NBRV)
| 0.181 Delayed Data As of Jun 30 |  -0.024 / -11.71%Today’s Change | 0.17 Today|||52-Week Range 1.40 | -69.78% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Schroeder Theodore R Chief Executive Officer |  Buy | 12/28/2021 | 100,000 | $0.57 | $57.0K | -67.76% |
Schroeder Theodore R Chief Executive Officer | Buy | 9/14/2021 | 50,000 | $1.13 | $56.5K | -83.30% |
Schroeder Theodore R Chief Executive Officer |  Sale | 1/29/2022 | 10,766 | $0.45 | $4.8K | -62.32% |
Naftzger John Christopher Secretary & General Counsel | Buy | 12/27/2021 | 7,000 | $0.59 | $4.1K | -68.18% |
Gelone Steven P President & Chief Operating Officer | Sale | 1/29/2022 | 3,483 | $0.45 | $1.6K | -62.32% |
Burgess Daniel D Director | Sale | 8/02/2021 | 1,125 | $1.20 | $1.4K | -84.29% |
Bourdow Carrie L Director | Sale | 8/02/2021 | 777 | $1.20 | $932.40 | -84.29% |
Rowland Charles A Jr Director | Sale | 8/02/2021 | 777 | $1.20 | $932.40 | -84.29% |
Webster Stephen W Director | Sale | 8/02/2021 | 777 | $1.20 | $932.40 | -84.29% |
Broom Colin Director | Sale | 8/02/2021 | 531 | $1.20 | $637.20 | -84.29% |
Page of 7